(Q64188105)
Statements
A Phase 1 Open-label, Multi-centre, Single-arm Trial to Evaluate the Safety and Pharmacokinetics (Including MUsT) of Twice Daily Topical Application of Delgocitinib Cream for 8 Weeks in Adults, Adolescents, and Children With Moderate to Severe Atopic Dermatitis (English)
0 references
20 February 2019
0 references
16 May 2020
0 references
44
0 references
2 year
0 references